Versant Venture Management as of Dec. 31, 2024
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 7 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Monte Rosa Therapeutics Common Stock (GLUE) | 45.2 | $39M | 5.7M | 6.94 | |
| CRISPR Therapeutics Common Shares (CRSP) | 22.6 | $20M | 499k | 39.36 | |
| Contineum Therapeutics Common Stock (CTNM) | 15.5 | $14M | 918k | 14.65 | |
| Skye Bioscience Common Stock (SKYE) | 6.5 | $5.7M | 2.0M | 2.83 | |
| Repare Therapeutics Common Stock (RPTX) | 4.0 | $3.5M | 2.6M | 1.31 | |
| Tempest Therapeutics Common Stock | 3.4 | $2.9M | 3.5M | 0.83 | |
| Adverum Biotechnologies Common Stock | 2.7 | $2.4M | 507k | 4.67 |
